Lv11
20 积分 2024-10-22 加入
AKT as a Therapeutic Target in Cancer
11分钟前
待确认
FDA approves 100th small-molecule kinase inhibitor
6天前
已关闭
Branching beyond bifunctional linkers: synthesis of macrocyclic and trivalent PROTACs
7天前
已完结
Induced proximity-based therapeutic modalities
19天前
已完结
A patent review of discoidin domain receptor 1 (DDR1) modulators (2014-present)
1个月前
已完结
BCR::ABL1 Proteolysis-targeting chimeras (PROTACs): The new frontier in the treatment of Ph+ leukemias?
1个月前
已完结
Structural basis for DCAF2 as a novel E3 ligase for PROTAC-mediated targeted protein degradation
1个月前
已完结
Finding a needle in the haystack: ADME and pharmacokinetics/pharmacodynamics characterization and optimization toward orally available bifunctional protein degraders
2个月前
已完结
Hydrophobic tagging of small molecules: an overview of the literature and future outlook
5个月前
已完结
An updated patent review of AKT inhibitors (2020 – present)
5个月前
已完结
Lipid-Based Liquid Crystals As Carriers for Antimicrobial Peptides: Phase Behavior and Antimicrobial Effect
皖公网安备34019202002308
